Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment Study completion moved earlier from May 1, 2027 to Dec 31, 2026 Sharda UniversityNot applicable NCT07549373
  2. Minor: IParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients Study completion pushed from Jun 26, 2026 to Mar 31, 2027 The Hospital for Sick ChildrenNot applicable NCT05968807
  3. Minor: Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion Interventions modified The Second Hospital of Anhui Medical UniversityNot applicable NCT07185022
  4. Minor: COINCIDE · Cardineurovascular dIsease and Obstructive Airway Disease Start date pushed from Oct 15, 2026 to Nov 2026 VASCage GmbHNot specified NCT07856667
  5. Minor: Using Facebook to Support Opioid Recovery Among American Indian Women Study completion pushed from Oct 31, 2026 to Oct 15, 2027 Mayo ClinicNot applicable NCT05995886
  6. Minor: Music Improvisation Training on Cognitive Function in Older Adults Study completion pushed from Jun 12, 2026 to Jun 12, 2027 University of California, San FranciscoNot applicable NCT06721390
  7. Minor: CHIP in Health and Disease Start date pushed from Oct 2026 to Nov 2026 VASCage GmbHNot specified NCT07780552
  8. Minor: Maastro Applicator in Rectal Cancer Study completion moved earlier from Apr 2031 to Oct 6, 2030 Maastricht Radiation OncologyNot applicable NCT06087718
  9. Minor: MDMA-assisted Therapy for Fibromyalgia Trial arms changed: 0 → 1 Spaulding Rehabilitation HospitalEarly Phase 1 NCT06066853
  10. Minor: COVID-19 Vaccine(s) in Children and Adults Enrollment closed, study ongoing BioNTech SEPhase 3 NCT07798648
  11. Minor: Depemokimab Compared With Mepolizumab · Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial completed GlaxoSmithKlinePhase 3 NCT05263934
  12. Minor: AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) · Anemia Enrollment closed, study ongoing Kind Pharmaceuticals LLCPhase 3 NCT07494409
  13. Minor: PF-06821497 (Mevrometostat) Works · Metastatic Castration-resistant Prostate Cancer Enrollment closed, study ongoing PfizerPhase 3 NCT06629779
  14. Minor: Balcinrenone/Dapagliflozin · Heart Failure and Impaired Kidney Function Enrollment closed, study ongoing AstraZenecaPhase 3 NCT06307652
  15. Minor: Linerixibat Long-term Safety, and Tolerability Study Trial completed GlaxoSmithKlinePhase 3 NCT04167358
  16. Minor: HRS-5965 Capsule in Primary IgA Nephropathy Enrollment closed, study ongoing Chengdu Suncadia Medicine Co., Ltd.Phase 3 NCT07014826
  17. Minor: CATALINA-2 · TORL-1-23 in Platinum-resistant Ovarian Cancer Enrollment closed, study ongoing TORL Biotherapeutics, LLCPhase 2 NCT06690775
  18. Minor: A2B395, an Allogeneic Logic-gated CAR T, · Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing A2 Biotherapeutics Inc.Phase 1/2 NCT06682793
  19. Minor: Microdystrophin Gene Transfer Study in Adolescents and · DMD Trial completed Solid Biosciences Inc.Phase 1/2 NCT03368742
  20. Minor: Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age Enrollment closed, study ongoing GlaxoSmithKlinePhase 1/2 NCT06702449
  21. Minor: SB17170 Phase 2 Trial in IPF Patients Trial completed SPARK BiopharmaPhase 2 NCT06747923
  22. Minor: CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) Trial completed Vittoria BiotherapeuticsPhase 1 NCT06420089
  23. Minor: CDR404 in HLA-A*02:01 · MAGE-A4 Expressing Solid Tumors Enrollment closed, study ongoing CDR-Life AGPhase 1 NCT06402201
  24. Minor: CX-5461 · Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation Enrollment closed, study ongoing Senhwa Biosciences, Inc.Phase 1 NCT04890613
  25. Minor: Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) Enrollment closed, study ongoing Sunkaky Medical CooperationNot applicable NCT07066267